Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Debt to Equity (2016 - 2026)

Insmed's Debt to Equity history spans 15 years, with the latest figure at $0.77 for Q1 2026.

  • Quarterly Debt to Equity fell 93.1% to $0.77 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.77 through Mar 2026, down 93.1% year-over-year, with the annual reading at $0.73 for FY2025, 81.07% down from the prior year.
  • Debt to Equity came in at $0.77 for Q1 2026, up from $0.73 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $30.17 in Q2 2024 to a low of -$26.2 in Q3 2022.
  • The 5-year median for Debt to Equity is $0.73 (2025), against an average of $1.05.
  • The largest YoY upside for Debt to Equity was 1614.93% in 2022 against a maximum downside of 2471.71% in 2022.
  • Insmed's Debt to Equity stood at $12.79 in 2022, then plummeted by 127.21% to -$3.48 in 2023, then skyrocketed by 211.08% to $3.87 in 2024, then crashed by 81.07% to $0.73 in 2025, then increased by 5.08% to $0.77 in 2026.
  • Per Business Quant, the three most recent readings for INSM's Debt to Equity are $0.77 (Q1 2026), $0.73 (Q4 2025), and $0.57 (Q3 2025).